Risk Factors of Clinical Relapses in Pediatric Luminal Crohn's Disease: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Risk Factors of Clinical Relapses in Pediatric Luminal Crohn's Disease: A Retrospective Cohort Study

Published:2022-01-17 Issue:4 Volume:117 Page:637-646
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Sassine Samuel,Djani Lisa,Cambron-Asselin Christine,Savoie Mathieu,Lin Yi Fan,Qaddouri Marwa,Zekhnine Souhila,Grzywacz Kelly,Groleau Véronique,Dirks Martha,Drouin Éric,Halac Ugur,Marchand Valérie,Girard Chloé,Courbette Olivier,Patey Natalie,Dal Soglio Dorothée,Deslandres Colette,Jantchou Prévost

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference56 articles.

1. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies;Ng;Lancet,2018

2. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort;Thia;Gastroenterology,2010

3. Clinical risk factors for complicated disease: How reliable are they?;Zallot;Dig Dis,2012

4. Predicting outcomes in pediatric Crohn's disease for management optimization: Systematic review and consensus statements from PIBD-ahead program;Ricciuto;Gastroenterology,2021

5. Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort study;Fumery;Dig Liver Dis,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consenso colombiano de la enfermedad inflamatoria intestinal pediátrica;Revista colombiana de Gastroenterología;2023-10-02

2. The State of Clinical Trials in Pediatric Inflammatory Bowel Disease;Gastroenterology Clinics of North America;2023-09

3. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—Children and Adolescents with IBD;Journal of the Canadian Association of Gastroenterology;2023-09-01

4. Current Role of Monoclonal Antibody Therapy in Pediatric IBD: A Special Focus on Therapeutic Drug Monitoring and Treat-to-Target Strategies;Children;2023-03-28